ETF Holdings Breakdown of BNTX

Stock NameBioNTech SE
TickerBNTX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09075V1026
LEI894500UZJ5LG1F8J1U58

News associated with BNTX

BioNTech SE (NASDAQ:BNTX) Shares Purchased by CANADA LIFE ASSURANCE Co
CANADA LIFE ASSURANCE Co boosted its position in BioNTech SE (NASDAQ:BNTX – Free Report) by 63.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,791 shares of the company’s stock after purchasing an additional 3,025 shares during the quarter. CANADA LIFE ASSURANCE Co’s […] - 2025-04-30 07:59:01
FNDF, MDT, BNTX, FERG: ETF Inflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab Fundamental International Large Company Index (Symbol: FNDF) where we have detected an approximate $136.9 million dollar inflow -- that's a 0. - 2025-04-28 15:09:26
Invesco Ltd. Lowers Holdings in BioNTech SE (NASDAQ:BNTX)
Invesco Ltd. lowered its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 1.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 86,753 shares of the company’s stock after selling 1,005 shares during the period. Invesco Ltd.’s holdings in BioNTech were worth $9,886,000 as of its most recent filing with […] - 2025-04-23 08:58:48
LPL Financial LLC Has $4.43 Million Stake in BioNTech SE (NASDAQ:BNTX)
LPL Financial LLC grew its holdings in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 4.9% during the fourth quarter, HoldingsChannel.com reports. The firm owned 38,860 shares of the company’s stock after acquiring an additional 1,800 shares during the quarter. LPL Financial LLC’s holdings in BioNTech were worth $4,428,000 as of its most recent […] - 2025-04-10 07:38:48
Arrowstreet Capital Limited Partnership Makes New Investment in BioNTech SE (NASDAQ:BNTX)
Arrowstreet Capital Limited Partnership acquired a new stake in shares of BioNTech SE (NASDAQ:BNTX – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 30,827 shares of the company’s stock, valued at approximately $3,513,000. A number of […] - 2025-04-09 08:26:59
Mitsubishi UFJ Asset Management Co. Ltd. Has $265,000 Stake in BioNTech SE (NASDAQ:BNTX)
Mitsubishi UFJ Asset Management Co. Ltd. reduced its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 20.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 2,285 shares of the company’s stock after selling 572 shares during the quarter. Mitsubishi UFJ Asset Management Co. […] - 2025-04-04 08:19:13
HC Wainwright Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price
BioNTech (NASDAQ:BNTX – Get Free Report) had its target price dropped by analysts at HC Wainwright from $150.00 to $145.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target would indicate a potential upside of 55.38% from the stock’s current price. A […] - 2025-04-03 05:54:45
BioNTech (NASDAQ:BNTX) Now Covered by Analysts at Citigroup
Citigroup started coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a report issued on Thursday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $145.00 target price on the stock. Other equities analysts have also issued reports about the stock. JPMorgan Chase & Co. cut their price target on shares […] - 2025-03-14 08:26:54
BMO Capital Markets Increases BioNTech (NASDAQ:BNTX) Price Target to $143.00
BioNTech (NASDAQ:BNTX – Get Free Report) had its price target boosted by investment analysts at BMO Capital Markets from $130.00 to $143.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. BMO Capital Markets’ target price indicates a potential upside of 42.56% from the company’s current price. […] - 2025-03-13 06:25:02
Canaccord Genuity Group Reiterates “Buy” Rating for BioNTech (NASDAQ:BNTX)
BioNTech (NASDAQ:BNTX – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Canaccord Genuity Group in a research note issued on Tuesday,Benzinga reports. They presently have a $171.44 price objective on the stock. Canaccord Genuity Group’s price target points to a potential upside of 70.91% from the company’s previous close. A […] - 2025-03-13 06:25:00
SVB Wealth LLC Buys Shares of 1,788 BioNTech SE (NASDAQ:BNTX)
SVB Wealth LLC bought a new stake in shares of BioNTech SE (NASDAQ:BNTX – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm bought 1,788 shares of the company’s stock, valued at approximately $204,000. A number of other hedge funds and other institutional investors have also recently bought and sold shares of BNTX. […] - 2025-03-07 10:05:05
BioNTech SE (NASDAQ:BNTX) Shares Sold by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. decreased its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 10.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,513 shares of the company’s stock after selling 418 shares during the period. Mirae Asset […] - 2025-02-13 08:32:55
BioNTech SE (NASDAQ:BNTX) Shares Sold by Fifth Third Bancorp
Fifth Third Bancorp cut its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 26.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 414 shares of the company’s stock after selling 148 shares during the quarter. Fifth Third Bancorp’s holdings in BioNTech […] - 2025-02-03 08:28:57

BNTX institutional holdings

The following institutional investment holdings of BNTX have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 47,360USD 4,488,781
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 47,360USD 4,488,781 2.1%
2025-05-08 IE00BZ0PKT83 (iShares Edge MSCI World Multifactor UCITS ETF USD (Acc) GBP) 5,412USD 512,949 2.1%
2025-05-08 IE00BYXPXK00 (iShares STOXX World Equity Multifactor UCITS ETF EUR Hedged (Acc)) 5,412USD 512,949 2.1%
2025-05-08 IE00BZ0PKV06 (iShares STOXX Europe Equity Multifactor UCITS ETF EUR (Acc)) 4,144USD 348,276
2025-05-08 IE00BG13YL86 (iShares Edge MSCI Europe Multifactor UCITS ETF EUR (Dist) USD) 4,144USD 348,276
Total =113,832 USD 10,700,012
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.